<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  xmlns:html="http://www.w3.org/1999/xhtml"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:prn="http://rss.prnewswire.com/ns/0.1/#"
  xmlns="http://purl.org/rss/1.0/"
>
  <channel rdf:about="http://www.prnewswire.co.uk/cgi/news/topic?id=725">
<!--

Issuers of news releases and not PR Newswire are solely responsible
for the accuracy of the content.

-->
    <title>PR Newswire: Science</title>
    <link>http://www.prnewswire.co.uk/cgi/news/topic?id=725</link>
    <description>Science Press releases distributed via PR Newswire.</description>
    <sy:updatePeriod>hourly</sy:updatePeriod>
    <sy:updateFrequency>5</sy:updateFrequency>
    <sy:updateBase>2005-01-01T00:00+00:00</sy:updateBase>
    <dc:publisher>PR Newswire Europe Ltd.</dc:publisher>
    <dc:rights>Copyright  © 1996-2008 PR Newswire Europe Ltd. All Rights Reserved.</dc:rights>
    <dc:language>en-US</dc:language>
    <dc:date>2009-11-19T20:33:03+00:00</dc:date>
    <image rdf:resource="http://www.prnewswire.com/global/homepage/images/logo.gif"/>

    <items>
      <rdf:Seq>

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272484" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272483" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272476" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272410" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272294" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272285" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272280" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272176" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272078" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272076" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272071" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272069" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=272017" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271929" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271919" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271909" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271818" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271811" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271804" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271730" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271728" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271691" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271652" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271654" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271655" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271603" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271614" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271623" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271163" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271098" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271077" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=271029" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270981" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270904" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270818" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270816" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270795" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270763" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270762" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270753" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270710" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270679" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270656" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270615" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270598" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270496" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270216" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270121" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270119" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=270050" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269925" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269900" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269892" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269887" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269884" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269750" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269738" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269625" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269589" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269486" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269275" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269258" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269213" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269212" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269162" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=269069" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268963" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268962" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268834" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268818" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268824" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268829" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=268701" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=267357" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=267046" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266898" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266869" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266829" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266792" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266579" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266347" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266288" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266289" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266290" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=266096" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265965" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265749" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265705" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265605" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265451" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265289" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265269" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265222" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=265208" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264785" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264786" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264673" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264580" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264578" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264557" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264524" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264499" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264453" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264406" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264342" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264248" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264232" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264233" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264234" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264189" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264168" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264006" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264007" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264008" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264009" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=264010" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263973" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263777" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263612" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263601" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263583" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263582" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263538" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263480" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263473" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263434" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263427" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263379" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263359" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263355" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263344" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263322" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263300" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263299" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263293" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=263181" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262980" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262861" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262865" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262647" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262456" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262367" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262363" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262254" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262180" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262168" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262152" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262153" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262157" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262090" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=262078" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261929" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261920" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261887" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261793" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261719" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261683" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261641" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261639" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261640" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261638" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261198" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261072" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=261005" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260980" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260981" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260978" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260934" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260922" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260919" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260909" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260873" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260826" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260756" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260672" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260617" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260519" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260493" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260489" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260337" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260306" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260154" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260149" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260117" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260123" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=260124" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259898" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259890" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259848" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259764" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259635" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259557" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259488" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259448" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259435" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259443" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259265" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259190" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259173" />

<rdf:li resource="http://www.prnewswire.co.uk/cgi/news/release?id=259174" />

      </rdf:Seq>
    </items>

    <textinput rdf:resource="http://199.230.26.105/fulltext"/>

  </channel>

  <image rdf:about="http://www.prnewswire.com/global/homepage/images/logo.gif">
    <title>PR Newswire: Science</title>
    <url>http://www.prnewswire.com/global/homepage/images/logo.gif</url>
    <link>http://www.prnewswire.co.uk/cgi/news/topic?id=725</link>
  </image>


  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272484">
    <title>L'étude POPular met en avant le système VerifyNow(R) en matière de test de réactivité plaquettaire</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272484</link>
	<dc:date>2009-11-19T20:28:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272483">
    <title>Das VerifyNow(R)-System wurde in der POPular-Vergleichsstudie von Thrombozytenaggregations-Reaktionstests herausgestellt</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272483</link>
	<dc:date>2009-11-19T20:21:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272476">
    <title>El sistema VerifyNow(R) destaca el estudio POPular que compara los restos de reactividad de las plaquetas</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272476</link>
	<dc:date>2009-11-19T19:40:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272410">
    <title>VerifyNow(R) System Highlighted in POPular Study Comparing Platelet Reactivity Tests</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272410</link>
	<dc:date>2009-11-19T13:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272294">
    <title>Ny nedkylningsmetod vid hjärtstopp kan rädda fler hjärnor under hjärtstillestånd</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272294</link>
	<dc:date>2009-11-18T16:55:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272285">
    <title>Scientific Pioneer Lectures on AcceleDent Science in Key United Kingdom Orthodontic Venues</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272285</link>
	<dc:date>2009-11-18T15:22:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272280">
    <title>Updating the Guidelines for Assessing Toxic Substances</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272280</link>
	<dc:date>2009-11-18T14:52:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272176">
    <title>Albireo Announces Positive Clinical Data on A3309 in Patients with  Chronic Idiopathic Constipation</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272176</link>
	<dc:date>2009-11-18T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272078">
    <title>Letzter Termin für die Nominierungen des internationalen Dan-David-Preises 2010 ist der 30. November 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272078</link>
	<dc:date>2009-11-17T15:35:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272076">
    <title>Date de clôture des nominations aux Prix Internationaux Dan David 2010 : le 30 novembre 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272076</link>
	<dc:date>2009-11-17T15:31:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272071">
    <title>Termine per la presentazione delle candidature per l'International Dan David Prize 2010: 30 novembre 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272071</link>
	<dc:date>2009-11-17T14:57:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272069">
    <title>Fecha límite para las nominaciones internacionales 2010 a los Premios Dan David:30 de noviembre de 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272069</link>
	<dc:date>2009-11-17T14:31:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=272017">
    <title>Deadline for 2010 International Dan David Prize Nominations: November 30, 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=272017</link>
	<dc:date>2009-11-17T11:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271929">
    <title>Une nouvelle méthode de refroidissement en arrêt cardiaque pourrait contribuer à la préservation des cellules cérébrales</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271929</link>
	<dc:date>2009-11-16T18:47:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271919">
    <title>Neues Kühlverfahren rettet potenziell Hirnfunktionen über einen Herzkreislaufstillstand hinweg</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271919</link>
	<dc:date>2009-11-16T16:31:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271909">
    <title>El nuevo método de enfriamiento de intra-paros podría salvar más cerebros durante paradas cardíacas</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271909</link>
	<dc:date>2009-11-16T14:13:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271818">
    <title>New Intra-Arrest Cooling Method May Save More Brains During Cardiac Arrest</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271818</link>
	<dc:date>2009-11-15T22:57:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271811">
    <title>Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271811</link>
	<dc:date>2009-11-15T20:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271804">
    <title>Synopsys and King Abdulaziz City of Science and Technology (KACST) Sign Agreement to Promote Knowledge-Based Society in Saudi Arabia</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271804</link>
	<dc:date>2009-11-14T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271730">
    <title>Le test ProFlu-ST(TM) de Prodesse reçoit la marque européenne CE</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271730</link>
	<dc:date>2009-11-12T20:03:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271728">
    <title>Der ProFlu-ST(TM)-Assay von Prodesse erhält CE-Kennzeichnung in Europa</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271728</link>
	<dc:date>2009-11-12T19:59:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271691">
    <title>El ensayo ProFlu-ST(TM) de Prodesse recibe la Marca CE europea</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271691</link>
	<dc:date>2009-11-12T13:41:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271652">
    <title>Tobira Therapeutics stellt auf der European AIDS Conference Ergebnisse mit TBR-652 vor</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271652</link>
	<dc:date>2009-11-12T11:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271654">
    <title>Tobira Therapeutics annonce la présentation des données portant sur TBR-652 à l'occasion de la conférence européenne sur le SIDA</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271654</link>
	<dc:date>2009-11-12T11:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271655">
    <title>Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271655</link>
	<dc:date>2009-11-12T11:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271603">
    <title>Prodesse's ProFlu-ST(TM) Assay Receives European CE Mark</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271603</link>
	<dc:date>2009-11-12T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271614">
    <title>Hypoglycemia Education - A Vital Weapon in the Battle to Conquer Diabetes</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271614</link>
	<dc:date>2009-11-12T00:01:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271623">
    <title>Hypoglykämie-Schulung - eine entscheidende Waffe im Kampf gegen Diabetes</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271623</link>
	<dc:date>2009-11-12T00:01:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271163">
    <title>Helix BioPharma Corp. schliesst Aufnahme von Patienten mit anogenitalen Warzen in seine Phase-II-Studie zu Topical Interferon Alpha-2b ab</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271163</link>
	<dc:date>2009-11-07T01:52:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271098">
    <title>Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271098</link>
	<dc:date>2009-11-06T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271077">
    <title>Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271077</link>
	<dc:date>2009-11-05T23:08:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=271029">
    <title>Saudi Prince Sultan Khaled Bin Sultan Bin Abdulaziz in the Netherlands for International Water Prize</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=271029</link>
	<dc:date>2009-11-05T12:45:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270981">
    <title>La société d'investissement privée Czura Thornton présente aujourd'hui Clearstone Central Laboratories en tant que dernier membre du groupe des sciences de la vie de Czura Thornton</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270981</link>
	<dc:date>2009-11-05T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270904">
    <title>Health Robotics Announces December Launch of the i.v.SOFT(TM) Workflow Engine at ASHP in Las Vegas</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270904</link>
	<dc:date>2009-11-04T14:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270818">
    <title>CNPV lance une série de modules haut de gamme à 72 cellules monocristallines de 125 mm à rendement élevé</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270818</link>
	<dc:date>2009-11-03T18:39:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270816">
    <title>CNPV bringt hochleistungsfähige 72-zellige, monokristalline 125-mm-Premium-Modulreihe auf den Markt</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270816</link>
	<dc:date>2009-11-03T18:33:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270795">
    <title>CNPV lanza su gama de módulo premium de 72 células mono cristalinas de alto rendimiento de 125 mm</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270795</link>
	<dc:date>2009-11-03T14:05:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270763">
    <title>MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270763</link>
	<dc:date>2009-11-03T09:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270762">
    <title>CNPV Launches High Performance 72-Cell 125mm Mono Crystalline Premium Module Series</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270762</link>
	<dc:date>2009-11-03T09:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270753">
    <title>Die private Investmentfirma Czura Thornton nimmt Clearstone Central Laboratories als neues Mitglied in die Unternehmensgruppe Thornton Life Science Group auf</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270753</link>
	<dc:date>2009-11-03T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270710">
    <title>Elsevier Partners With Universities Around the Globe to Share Best Practices in Webinar Series for Librarians and Researchers</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270710</link>
	<dc:date>2009-11-02T18:07:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270679">
    <title>Abbott's XIENCE PRIME(TM) and XIENCE V(R) Receive Indications in Europe for Treatment of Patients with Diabetes</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270679</link>
	<dc:date>2009-11-02T14:51:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270656">
    <title>Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270656</link>
	<dc:date>2009-11-02T13:15:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270615">
    <title>Nuevolution Announces Receipt of Milestone Payment From Merck &amp;amp; Co., Inc.</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270615</link>
	<dc:date>2009-11-02T09:49:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270598">
    <title>InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270598</link>
	<dc:date>2009-11-02T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270496">
    <title>London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270496</link>
	<dc:date>2009-10-30T15:23:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270216">
    <title>BASF Podcast: The Chemical Reporter - How Does the Non-Stick Surface in a Pan Work?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270216</link>
	<dc:date>2009-10-28T12:36:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270121">
    <title>Simbionix stellt Bronchoskopie-Training der nächsten Generation vor</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270121</link>
	<dc:date>2009-10-27T23:01:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270119">
    <title>Simbionix présente une solution de nouvelle génération pour la formation en bronchoscopie</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270119</link>
	<dc:date>2009-10-27T23:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=270050">
    <title>Simbionix Introduces the Next Generation in Bronchoscopy Training</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=270050</link>
	<dc:date>2009-10-27T13:55:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269925">
    <title>Se anuncia la Waterloo Global Science Initiative</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269925</link>
	<dc:date>2009-10-26T19:06:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269900">
    <title>Video: un'iniezione di terapia genica e i bambini affetti da cecità congenita ora possono vedere</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269900</link>
	<dc:date>2009-10-26T16:13:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269892">
    <title>Annonce de la Waterloo Global Science Initiative</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269892</link>
	<dc:date>2009-10-26T15:09:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269887">
    <title>Ankündigung der Waterloo Global Science Initiative</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269887</link>
	<dc:date>2009-10-26T14:21:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269884">
    <title>Vidéo : Une injection de thérapie génique suffit pour redonner la vue à des enfants souffrant de cécité congénitale</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269884</link>
	<dc:date>2009-10-26T14:15:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269750">
    <title>UW &amp;amp; PI to Host International Conference to Help Advance Science Policy-making</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269750</link>
	<dc:date>2009-10-25T23:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269738">
    <title>Video: One Shot of Gene Therapy and Children with Congenital Blindness Can Now See</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269738</link>
	<dc:date>2009-10-24T18:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269625">
    <title>MAQUET Cardiovascular reçoit l'autorisation de marquage CE pour MEGA(TM), le premier cathéter à ballonnet intra-aortique du monde de 8 Frenchs et 50 cc</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269625</link>
	<dc:date>2009-10-22T18:16:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269589">
    <title>MAQUET Cardiovascular erhält CE-Kennzeichnung für MEGA(TM), den weltweit ersten intraaortalen 8-French-50-cc-Ballonkatheter</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269589</link>
	<dc:date>2009-10-22T11:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269486">
    <title>MAQUET Cardiovascular Receives CE Approval for MEGA(TM), the World's First 8Fr. 50cc Intra-Aortic Balloon Catheter</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269486</link>
	<dc:date>2009-10-21T17:16:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269275">
    <title>&quot;Expanding the Perimeter&quot;, en el Stephen Hawking Centre del PI</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269275</link>
	<dc:date>2009-10-20T10:36:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269258">
    <title>Ask a Nobel Laureate on YouTube</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269258</link>
	<dc:date>2009-10-20T09:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269213">
    <title>Élargir le périmètre du centre Stephen Hawking au PI</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269213</link>
	<dc:date>2009-10-20T04:35:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269212">
    <title>Perimeter des PI wird um das Stephen Hawking Centre erweitert</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269212</link>
	<dc:date>2009-10-20T04:27:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269162">
    <title>Expanding the Perimeter With The Stephen Hawking Centre at PI</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269162</link>
	<dc:date>2009-10-19T17:43:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=269069">
    <title>NextDocs and Adlib Celebrate The Success of Their SharePoint Partnership, Bringing SharePoint-based Document Management to the Life Sciences Industry</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=269069</link>
	<dc:date>2009-10-19T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268963">
    <title>Clinical Center of Serbia, Institute for Cardiovascular Diseases Treats First Patient in Trial of Pioneering Stem Cell-Derived Therapy for Heart Failure</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268963</link>
	<dc:date>2009-10-16T10:05:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268962">
    <title>Elsevier's BrainNavigator Research Tool to Launch new Features at Neuroscience 2009 Show</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268962</link>
	<dc:date>2009-10-16T10:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268834">
    <title>Biocartis Raises EUR10 Million in Series A Financing Round</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268834</link>
	<dc:date>2009-10-15T08:09:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268818">
    <title>Allumage au laser dans l'espace</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268818</link>
	<dc:date>2009-10-15T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268824">
    <title>Laser Ignition in Space</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268824</link>
	<dc:date>2009-10-15T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268829">
    <title>Ignición láser en el espacio</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268829</link>
	<dc:date>2009-10-15T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=268701">
    <title>BASF Podcast: The Chemical Reporter - What is the Chemistry Behind a Permanent Wave Hairstyle?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=268701</link>
	<dc:date>2009-10-14T10:36:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=267357">
    <title>BASF Podcast: The Chemical Reporter - Why Does Fluoride Make Your Teeth Hard?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=267357</link>
	<dc:date>2009-09-30T10:38:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=267046">
    <title>Elsevier Launches SciVal Funding Solution to Help U.S. Research Institutions Better Compete for Grants</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=267046</link>
	<dc:date>2009-09-28T05:09:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266898">
    <title>30th Anniversary Edition of Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases is More Relevant Than Ever</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266898</link>
	<dc:date>2009-09-24T08:47:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266869">
    <title>HIV Vaccine Study First to Show Some Effectiveness in Preventing HIV</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266869</link>
	<dc:date>2009-09-24T06:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266829">
    <title>DuPont Titanium Technologies annonce une hausse des prix pour ses produits de dioxyde de titane Ti-Pure(R) en Europe, au Moyen-Orient et en Afrique</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266829</link>
	<dc:date>2009-09-23T17:25:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266792">
    <title>DuPont Titanium Technologies Announces a Price Increase for Ti-Pure(R) Titanium Dioxide Products in Europe, Middle East and Africa</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266792</link>
	<dc:date>2009-09-23T13:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266579">
    <title>Accredited Construct Specific PCR Test for Recently Detected Unapproved GM Flax/Linseed FP967/CDC Triffid Available Through Genetic ID</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266579</link>
	<dc:date>2009-09-22T09:21:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266347">
    <title>NeuroFocus Names Dr. Steven Miller to Head Global Neurological Laboratory Operations</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266347</link>
	<dc:date>2009-09-18T12:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266288">
    <title>Presentación del progreso de la terapia MitraClip(R) en TCT 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266288</link>
	<dc:date>2009-09-17T14:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266289">
    <title>Stetige Fortschritte bei der MitraClip(R)-Therapie auf der TCT 2009 vorgestellt</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266289</link>
	<dc:date>2009-09-17T14:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266290">
    <title>Les progrès continus du traitement MitraClip(R) sont soulignés à l'occasion de la conférence TCT 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266290</link>
	<dc:date>2009-09-17T14:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=266096">
    <title>BASF Podcast: the Chemical Reporter - Why do Potatoes get Softer When you Cook Them, While Eggs get Harder?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=266096</link>
	<dc:date>2009-09-16T10:39:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265965">
    <title>Ongoing Progress of MitraClip(R) Therapy Highlighted at TCT 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265965</link>
	<dc:date>2009-09-15T14:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265749">
    <title>ICIS Chemical Business Unveils Top 100 Chemical Companies</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265749</link>
	<dc:date>2009-09-14T14:50:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265705">
    <title>ICIS Chemical Business Unveils Top 100 Chemical Companies</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265705</link>
	<dc:date>2009-09-14T10:28:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265605">
    <title>Scopus And Thailand Research Fund Announce 2009 Nominations For TRF-CHE Researcher Awards</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265605</link>
	<dc:date>2009-09-11T16:18:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265451">
    <title>Elsevier Joins InChI Trust as a Charter Member</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265451</link>
	<dc:date>2009-09-10T09:15:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265289">
    <title>Sustancia química única número 50 millones registrada en CAS REGISTRY(SM)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265289</link>
	<dc:date>2009-09-09T08:45:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265269">
    <title>50-millionste einzigartige chemische Substanz im CAS REGISTRY(SM) erfasst</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265269</link>
	<dc:date>2009-09-09T07:45:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265222">
    <title>Enregistrement dans le CAS REGISTRY(SM) de la 50 millionième substance chimique unique</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265222</link>
	<dc:date>2009-09-09T05:47:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=265208">
    <title>50 Millionth Unique Chemical Substance Recorded in CAS REGISTRY(SM)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=265208</link>
	<dc:date>2009-09-08T22:17:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264785">
    <title>B-R-A-H-M-S et Thermo Fisher Scientific unissent leurs forces pour devenir un leader du diagnostic spécialisé</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264785</link>
	<dc:date>2009-09-03T04:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264786">
    <title>B-R-A-H-M-S and Thermo Fisher Scientific Join Forces to Create a Leader in Specialty Diagnostics</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264786</link>
	<dc:date>2009-09-03T04:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264673">
    <title>BASF Podcast: The Chemical Reporter - What's the Significance of That Percentage Number on the Label of a Bottle Containing an Alcoholic Beverage?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264673</link>
	<dc:date>2009-09-02T10:48:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264580">
    <title>New Insights Link Low HDL-Cholesterol and Elevated Triglycerides With Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264580</link>
	<dc:date>2009-09-01T12:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264578">
    <title>Pitavastatin is Non-Inferior to Atorvastatin and Simvastatin and Demonstrates Sustained Efficacy and Tolerability Over 52 Weeks</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264578</link>
	<dc:date>2009-09-01T12:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264557">
    <title>Global Biomaterials Market Worth US$58.1 Billion by 2014</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264557</link>
	<dc:date>2009-09-01T09:44:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264524">
    <title>Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264524</link>
	<dc:date>2009-09-01T06:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264499">
    <title>Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264499</link>
	<dc:date>2009-08-31T16:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264453">
    <title>Elsevier Publishes Jiang Zemin's Book on China's Energy Policy in English</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264453</link>
	<dc:date>2009-08-31T10:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264406">
    <title>Blood Test May Predict Course of MS</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264406</link>
	<dc:date>2009-08-31T00:32:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264342">
    <title>Bavarian Nordic A/S - Half Year Interim Report 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264342</link>
	<dc:date>2009-08-28T07:45:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264248">
    <title>Innovative Danish Design Provides New Solutions to Climate Issues</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264248</link>
	<dc:date>2009-08-27T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264232">
    <title>La innovadora Danish Design ofrece nuevas soluciones a los problemas climáticos</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264232</link>
	<dc:date>2009-08-27T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264233">
    <title>Les innovations du design danois fournissent de nouvelles solutions contre le changement climatique</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264233</link>
	<dc:date>2009-08-27T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264234">
    <title>Innovatives dänisches Design bietet neue Lösungen für Klimaprobleme</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264234</link>
	<dc:date>2009-08-27T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264189">
    <title>Advances in Processing Technology Expand Markets for Natural Graphite</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264189</link>
	<dc:date>2009-08-26T15:25:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264168">
    <title>Darwin Sails Again: 'on the Future of Species'</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264168</link>
	<dc:date>2009-08-26T11:42:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264006">
    <title>Erste schwedische Patienten mit MitraClip(R) behandelt</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264006</link>
	<dc:date>2009-08-24T17:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264007">
    <title>Les premiers patients suédois reçoivent la thérapie MitraClip(R)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264007</link>
	<dc:date>2009-08-24T17:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264008">
    <title>Första svenska patienterna behandlade med MitraClip(R)-systemet</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264008</link>
	<dc:date>2009-08-24T17:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264009">
    <title>Los primeros pacientes suecos reciben la terapia basada en MitraClip(R)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264009</link>
	<dc:date>2009-08-24T17:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=264010">
    <title>First Swedish Patients Receive MitraClip(R) Therapy</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=264010</link>
	<dc:date>2009-08-24T17:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263973">
    <title>Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263973</link>
	<dc:date>2009-08-24T12:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263777">
    <title>BASF Podcast: The Chemical Reporter - What is Carbon Dioxide?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263777</link>
	<dc:date>2009-08-19T10:10:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263612">
    <title>PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263612</link>
	<dc:date>2009-08-17T15:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263601">
    <title>CAS REGISTRY(SM), el estándar global para la investigación química, se acerca al hito de los 50 millones de registros</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263601</link>
	<dc:date>2009-08-17T13:05:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263583">
    <title>CAS REGISTRY(SM), la norme globale en matière de recherche chimique se rapproche de son 50 millionième enregistrement</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263583</link>
	<dc:date>2009-08-17T09:18:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263582">
    <title>Weltweit für chemische Forschung massgebliche Datenbank CAS REGISTRY(SM) bald mit 50 Millionen erfassten Substanzen</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263582</link>
	<dc:date>2009-08-17T09:14:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263538">
    <title>CAS REGISTRY(SM), the Global Standard for Chemical Research, Approaches 50 Millionth Registration Milestone</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263538</link>
	<dc:date>2009-08-16T18:52:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263480">
    <title>BlackLight Power, Inc. annonce la validation indépendante de la source inédite d'énergie innovante fondée sur un nouvel état de l'atome d'hydrogène et des propriétés chimiques permettant une régénération continue</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263480</link>
	<dc:date>2009-08-14T01:06:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263473">
    <title>BlackLight Power, Inc. meldet unabhängige Validierung der bahnbrechenden neuen, auf einer neuen Form von Wasserstoff und neuen chemischen Konzepten beruhenden kontinuierlich regenerierbaren Energiequelle</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263473</link>
	<dc:date>2009-08-13T22:12:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263434">
    <title>BlackLight Power, Inc. anuncia validación de una fuente de energía basada en una nueva forma de hidrógeno</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263434</link>
	<dc:date>2009-08-13T12:02:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263427">
    <title>NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza Vaccines</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263427</link>
	<dc:date>2009-08-13T11:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263379">
    <title>Amsterdam Molecular Therapeutics Reports Half Year Results 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263379</link>
	<dc:date>2009-08-13T05:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263359">
    <title>Epix Pharmaceuticals, Inc. annonce que le PRX-07034 Therapeutics - CNS Phase 2 fera partie de la propriété intellectuelle qui sera offerte aux enchères le 30 septembre 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263359</link>
	<dc:date>2009-08-12T18:19:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263355">
    <title>Science Communication to Take the Stage at Annual AAAS Meeting in San Francisco</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263355</link>
	<dc:date>2009-08-12T16:36:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263344">
    <title>BlackLight Power, Inc. Announces Independent Validation of Breakthrough New Energy Source Based on a New Form of Hydrogen and Chemistry Capable of Continuous Regeneration</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263344</link>
	<dc:date>2009-08-12T13:37:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263322">
    <title>Epix Pharmaceuticals, Inc. anuncia la subasta de PRX-07034 Therapeutics - CNS Fase 2</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263322</link>
	<dc:date>2009-08-12T10:34:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263300">
    <title>SQM Reports Earnings for the First Half of 2009</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263300</link>
	<dc:date>2009-08-12T01:47:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263299">
    <title>Epix Pharmaceuticals, Inc. gibt bekannt, dass PRX-07034 Therapeutics - CNS Phase 2 Teil des geistigen Eigentums sein wird, das im Rahmen der am 30. September 2009 stattfindenden Auktion zum Verkauf angeboten wird</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263299</link>
	<dc:date>2009-08-12T01:27:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263293">
    <title>Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263293</link>
	<dc:date>2009-08-11T19:28:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=263181">
    <title>Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=263181</link>
	<dc:date>2009-08-10T12:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262980">
    <title>BASF Podcast: The Chemical Reporter - What is the Radiocarbon Dating Method?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262980</link>
	<dc:date>2009-08-05T10:25:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262861">
    <title>Behandling af kronisk lymfatisk leukæmi (CLL)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262861</link>
	<dc:date>2009-08-04T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262865">
    <title>Novel Chemotherapy Agent Bendamustine Significantly More Effective First-Line Therapy Than Chlorambucil in CLL</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262865</link>
	<dc:date>2009-08-04T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262647">
    <title>Call for Application: Creative Young Minds Are Invited to Unique Innovation-Camp in Berlin</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262647</link>
	<dc:date>2009-07-30T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262456">
    <title>GBP10m Knowledge Transfer Deal Signed by the University of Surrey and the National Physical Laboratory (NPL)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262456</link>
	<dc:date>2009-07-28T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262367">
    <title>Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262367</link>
	<dc:date>2009-07-27T09:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262363">
    <title>DuPont Titanium Technologies Announces a Price Increase for Ti-Pure(R) Titanium Dioxide Products in the Euro Markets of Europe and North Africa</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262363</link>
	<dc:date>2009-07-27T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262254">
    <title>UvA en ARCADIS: Einde Blauwalgplaag in Borgerswold Veendam</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262254</link>
	<dc:date>2009-07-23T09:05:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262180">
    <title>BASF Podcast: The Chemical Reporter - Why Does Silver Inhibit Bacterial Growth?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262180</link>
	<dc:date>2009-07-22T10:15:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262168">
    <title>University of Lodz Invests in the Unique Cellaxess(R)HT System for Research on Multidrug Resistance Genes in Cancer</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262168</link>
	<dc:date>2009-07-22T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262152">
    <title>Die Universität von Lodz investiert in das einzigartige Cellaxess(R)HT System zur Erforschung von Multidrug-Resistenz-Genen bei Krebs</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262152</link>
	<dc:date>2009-07-22T06:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262153">
    <title>La Universidad de Lodz invierte en el sistema único Cellaxess(R)HT para investigación sobre los genes de resistencia en múltiples fármacos para casos de cáncer</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262153</link>
	<dc:date>2009-07-22T06:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262157">
    <title>L'université de Lodz investit dans le système unique Cellaxess(R)HT pour sa recherche sur les gènes de résistance pléiotropique aux médicaments dans le cadre de la lutte contre le cancer</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262157</link>
	<dc:date>2009-07-22T06:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262090">
    <title>UK Animal Experiments at 22 Year High, Back to Late 1980s Levels. Science Needs a 'Roadmap to Replacement' Says Dr Hadwen Trust For Humane Research</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262090</link>
	<dc:date>2009-07-21T11:31:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=262078">
    <title>Swissmedic erteilt Debiopharm die Marktzulassung für Moapar(R)</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=262078</link>
	<dc:date>2009-07-21T09:54:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261929">
    <title>DuPont Titanium Technologies annonce une augmentation des prix pour les produits en dioxyde de titane Ti-Pure(R) sur les marchés en dollars d'Europe de l'Est, du Moyen-Orient et d'Afrique</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261929</link>
	<dc:date>2009-07-17T12:43:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261920">
    <title>DuPont Titanium Technologies Announces a Price Increase for Ti-Pure(R) Titanium Dioxide Products in the Dollar Markets of Eastern Europe, Middle East and Africa</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261920</link>
	<dc:date>2009-07-17T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261887">
    <title>ChemAxon Launches JChem for Excel</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261887</link>
	<dc:date>2009-07-16T16:50:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261793">
    <title>Canadian Researchers Discover Gene Related to the Appearance of Aging</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261793</link>
	<dc:date>2009-07-15T17:21:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261719">
    <title>Sartorius Stedim Biotech Partners With Cell Culture Media Specialist SAFC Biosciences(R) to Provide World-Class Fluid Management and Liquid/Powder System Solutions</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261719</link>
	<dc:date>2009-07-14T18:44:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261683">
    <title>Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261683</link>
	<dc:date>2009-07-14T13:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261641">
    <title>Schweizer Team nutzt transkraniellen MRT-gestützten, fokussierten Ultraschall zur Behandlung von funktionellen Störungen des Gehirns</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261641</link>
	<dc:date>2009-07-14T07:37:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261639">
    <title>Un equipo suizo utiliza la ecografía transcraneal por RM en pacientes con trastorno cerebral funcional</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261639</link>
	<dc:date>2009-07-14T07:35:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261640">
    <title>A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261640</link>
	<dc:date>2009-07-14T07:35:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261638">
    <title>Une équipe suisse utilise les ultrasons concentrés guidés par résonance magnétique transcrâniens pour traiter les patients atteints de troubles fonctionnels cérébraux</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261638</link>
	<dc:date>2009-07-14T07:33:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261198">
    <title>The Neuchatel Institute of Microengineering (IMT) of EPFL and BrightView Systems Announce Collaboration for Solar Cell Production Process Optimization Solutions</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261198</link>
	<dc:date>2009-07-08T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261072">
    <title>It may be the 40th Anniversary of the First Lunar Landing, but an E&amp;amp;T Survey has Revealed That a Shocking 25% of the British Public Refuse to Believe man has Walked on the Moon!</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261072</link>
	<dc:date>2009-07-07T07:15:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=261005">
    <title>New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=261005</link>
	<dc:date>2009-07-06T11:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260980">
    <title>Les climatologues internationaux majeurs appellent les dirigeants mondiaux à s'engager envers le pic d'émissions mondiales de 2020</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260980</link>
	<dc:date>2009-07-06T08:29:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260981">
    <title>International Führende Klimaforscher Fordern Weltpolitiker Auf, die Globale Emissions-Höchstbelastung im Jahr 2020 zu Erreichen</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260981</link>
	<dc:date>2009-07-06T08:29:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260978">
    <title>Leading International Climate Scientists Call on World Leaders for Global Emissions Peak by 2020</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260978</link>
	<dc:date>2009-07-06T08:16:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260934">
    <title>Mars joue un rôle phare lors de la rencontre des Lauréats du prix Nobel et de l'exposition estivale sur le développement durable en Allemagne</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260934</link>
	<dc:date>2009-07-03T20:52:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260922">
    <title>CSA Group Increases Global Certification and Testing Capabilities With Acquisition of UK-Based SIRA</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260922</link>
	<dc:date>2009-07-03T16:30:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260919">
    <title>Mars, clave en la reunión de los premios Nobel y la exposición de sostenibilidad de verano en Alemania</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260919</link>
	<dc:date>2009-07-03T15:59:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260909">
    <title>Mars Plays Key Role at Meeting of Nobel Laureates and Summer-Long Sustainability Exhibition in Germany</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260909</link>
	<dc:date>2009-07-03T10:17:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260873">
    <title>Marie Curie Tops Poll of the Most Inspirational Women in Science</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260873</link>
	<dc:date>2009-07-02T16:20:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260826">
    <title>Soins de soutien pour les patients souffrant de cancer : Le palonosétron, antagoniste des 5-HT3 recommandé dans la prévention de vomissements par la MASCC et l'ESMO</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260826</link>
	<dc:date>2009-07-02T09:41:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260756">
    <title>Cuidados paliativos en el cáncer: palonosetron es el antagonista 5-HT3 recomendado para prevención de la emesis por MASCC/ESMO</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260756</link>
	<dc:date>2009-07-01T13:15:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260672">
    <title>Omega and the Lunar Pioneers</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260672</link>
	<dc:date>2009-06-30T19:33:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260617">
    <title>Supportive Care in Cancer: Palonosetron Recommended 5-HT3 Antagonist for Emesis Prevention by MASCC/ESMO</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260617</link>
	<dc:date>2009-06-30T12:52:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260519">
    <title>Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260519</link>
	<dc:date>2009-06-29T13:50:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260493">
    <title>Bassam Jalgha from Lebanon Wins &quot;Stars of Science&quot;</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260493</link>
	<dc:date>2009-06-29T10:17:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260489">
    <title>Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260489</link>
	<dc:date>2009-06-29T09:19:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260337">
    <title>ONGLYZA(TM) (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260337</link>
	<dc:date>2009-06-25T16:31:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260306">
    <title>O2h and Hypoxium Announce an Agreement to Offer Hypoxium's Specialised In Vitro, Cell-Based Oncology Assays via O2h's Biology Affiliate Program</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260306</link>
	<dc:date>2009-06-25T11:14:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260154">
    <title>BASF Podcast: The Chemical Reporter - Why does cream turn to whipped cream when you whip it?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260154</link>
	<dc:date>2009-06-24T11:12:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260149">
    <title>BASF Podcast: Option for Climate Protection - Gas Scrubbing Captures CO2 From Flue Gases</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260149</link>
	<dc:date>2009-06-24T10:47:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260117">
    <title>Biovista Inc. annonce des résultats d'efficacité positifs dans un pré-essai clinique de BVA-601, son médicament repositionné pour traiter l'épilepsie</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260117</link>
	<dc:date>2009-06-24T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260123">
    <title>Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260123</link>
	<dc:date>2009-06-24T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=260124">
    <title>Biovista Inc. gibt vorklinisch getestete positive Wirksamkeit seines neu positionierten Epilepsie-Medikaments BVA-601 bekannt</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=260124</link>
	<dc:date>2009-06-24T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259898">
    <title>CEM remporte le prix &amp;lt;&amp;lt; Presidential Green Chemistry Challenge Award &amp;gt;&amp;gt; pour son analyseur de protéines rapide Sprint</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259898</link>
	<dc:date>2009-06-22T22:54:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259890">
    <title>CEM wurde für den Sprint Rapid Protein Analyzer mit einem Presidential Green Chemistry Challenge Award ausgezeichnet</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259890</link>
	<dc:date>2009-06-22T20:17:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259848">
    <title>CEM Wins Presidential Green Chemistry Challenge Award for the Sprint Rapid Protein Analyzer</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259848</link>
	<dc:date>2009-06-22T13:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259764">
    <title>&quot;Stars of Science&quot;: 2 Projects Will Compete for the $300,000 Prize</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259764</link>
	<dc:date>2009-06-21T09:55:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259635">
    <title>/C O R R E C T I O N -- Elsevier/</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259635</link>
	<dc:date>2009-06-18T13:28:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259557">
    <title>Epistem obtient l'accréditation au Crédit d'Impôt Recherche par le gouvernement français</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259557</link>
	<dc:date>2009-06-18T05:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259488">
    <title>Elsevier Honored as &quot;The Most Influential Publisher of the Last 100 Years in BioMedicine and the Life Sciences&quot; by the Special Libraries Association</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259488</link>
	<dc:date>2009-06-17T12:21:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259448">
    <title>Original or Copy?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259448</link>
	<dc:date>2009-06-17T08:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259435">
    <title>Original ou copie ?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259435</link>
	<dc:date>2009-06-17T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259443">
    <title>¿Original o copia?</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259443</link>
	<dc:date>2009-06-17T07:00:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259265">
    <title>Le Festival &amp;lt;&amp;lt; Du quantum au cosmos &amp;gt;&amp;gt; organisé par l'Institut canadien Perimeter sera retransmis sur Internet et à la télévision</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259265</link>
	<dc:date>2009-06-15T21:52:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259190">
    <title>Honour for Top Scientist</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259190</link>
	<dc:date>2009-06-15T10:31:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259173">
    <title>El Festival &quot;Quantum to Cosmos&quot; del Perimeter Institute de Canadá será in-situ, online y en televisión</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259173</link>
	<dc:date>2009-06-15T09:45:00+0000</dc:date>
    
  </item>

  <item rdf:about="http://www.prnewswire.co.uk/cgi/news/release?id=259174">
    <title>Canada's Perimeter Institute &quot;Quantum to Cosmos&quot; Festival to be On-site, Online and On TV</title>
    <link>http://www.prnewswire.co.uk/cgi/news/release?id=259174</link>
	<dc:date>2009-06-15T09:45:00+0000</dc:date>
    
  </item>


  <textinput rdf:about="http://199.230.26.105/fulltext">
    <title>Search Recent</title>
    <description>Search PR Newswire's archived press releases from the last three working days.</description>
    <name>SEARCH</name>
    <link>http://199.230.26.105/fulltext</link>
  </textinput>

</rdf:RDF>
